- Conformis Inc (NASDAQ:CFMS) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient’s membership of healthcare facilities.
- The agreement gives increased access to the entire Conformis knee and hip portfolio to Vizient’s membership base, which comprises academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute health care providers.
- The offering includes:
- Identity Imprint, a personalized knee replacement system.
- Image-to-Implant Platinum Services Program, a patient-elected deluxe upgrade option to obtain a fully personalized knee replacement implant.
- Cordera Match Hip System, a personalized primary hip replacement solution.
- Researchers at the University of Washington in Seattle found that fully personalized total knee arthroplasty is cost-effective compared to a standard, off-the-shelf implant.
- Ongoing research suggests that fully personalized implants further reduce total costs to the healthcare system because patients recover more quickly and are less likely to require follow-up corrective (revision) surgeries.
- Price Action: CFMS shares are up 4.31% at $0.27 during the premarket session on the last check Tuesday.
Here’s How Much You Would Have Made Owning American Water Works Stock In The Last 10 Years
American Water Works (NYSE:AWK) has outperformed the market over the past 10 years by 3.47% on an annualized basis producing an average annual return of 14.15%. Currently, American Water Works has a market capitalization of $25.06 billion.
